Pasar al contenido principal

GENETICS OF AUTOIMMUNE DISEASES

RYC-2014-16458

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The potential of PTPN22 as a therapeutic target for rheumatoid arthritis

  • Carmona, Francisco David
  • Martín, J.
PTPN22 encodes a lymphoid-specific tyrosine phosphatase (LYP) that is a master regulator of the immune response. This gene is a major susceptibility factor for a wide range of autoimmune conditions, including rheumatoid arthritis (RA) for which it represents the strongest non-HLA contributor to disease risk. A missense PTPN22 allele (R620W) affecting the protein-protein interaction of LYP with other relevant players was described as the functional variant of the association. This review will focus on the role of PTPN22 in the pathogenic mechanisms underlying RA predisposition and discuss the possibility of developing LYP-based treatment strategies with a potential application in clinical practice. Areas covered: This review covers the literature showing how PTPN22 is implicated in signalling pathways involved in the autoimmune and autoinflammatory processes underlying RA. Insights obtained from studies aimed at developing novel selective LYP suppressors for treating RA are summarized. Expert opinion: Targeting key risk factors during the early steps of the disease may represent a good strategy to accomplish complete disease remission. As cumulating evidences suggest that PTPN22 R620W is a gain-of-function variant, a growing interest in developing LYP inhibitors has arisen. The potential efficacy and possible application of such compounds are discussed., FDC was recipient of a grant from the 'Ramon y Cajal' programme of the Spanish Ministry of Economy and Competitiveness (RYC-2014-16458). JM was founded by Instituto de Salud Carlos III (ISCIII), Spain, through the RETICS Program RD16/0012/0004 (RIER), and the EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS (ref: 115565)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Association between Genetic Polymorphisms of Inflammatory Response Genes and Acute Pancreatitis

  • Rodríguez-Nicolás, Antonio
  • Jiménez, Pilar
  • Carmona, Francisco David
  • Martín, J.
  • Matas Cobos, Ana M.
  • Ruiz-Cabello, Francisco
  • Redondo-Cerezo, Eduardo
Inflammation plays a central role in the pathophysiology of acute pancreatitis (AP). We hypothesized that changes in the function of key components of the inflammatory cascade, caused by genetic polymorphisms, could determine the development and/or severity of AP. We studied the following polymorphisms in 269 patients: IL23R rs11209026, TNF rs1800629, RIPK2 rs42490, NOD2 rs9302752, MCP1 rs1024611 and NFKB1 rs28362491. The rs11209026 A allele was related to the presence of AP (p = 0.007261; OR = 1 .523). Epistasis analysis revealed that AP susceptibility was increased by interaction between IL23R rs11209026 and TNF rs1800629 (p = 1.205 x 10(-5); ORinteraction = 4.031). The rs42490-G allele was associated with an increased risk of severe pancreatitis (p = 0.01583; OR = 2.736), severe or moderately severe pancreatitis (p = 0.04206; OR = 1.609), and death (p = 0.03226; OR = 3.010). In conclusion, these results point to a plausible role for genetic polymorphisms in IL23R and RIPK2 in the development and severity of AP., This work was supported by the grants from Instituto de Salud Carlos III co-financed by the European Regional Development Fund [PI11/01386, PI16/00752, RETIC RD 06/020, RD09/0076/00165] and the Andalusian Regional Government in Spain (CTS-143). FDC received a "Ramon y Cajal" grant [RYC-2014-16458] from the Ministerio de Economia, Industria y Competitividad, Spain., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of a 3 '-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study

  • López-Mejías, Raquel
  • Carmona, Francisco David
  • Genre, Fernanda
  • Remuzgo-Martínez, Sara
  • González-Juanatey, Carlos
  • Corrales, Alfonso
  • Vicente, Esther
  • Pulito-Cueto, Verónica
  • Miranda-Filloy, J. A.
  • Ramírez Huaranga, Marco A.
  • Blanco, Ricardo
  • Robustillo-Villarino, Montserrat
  • Rodríguez-Carrio, Javier
  • Alperi-López, Mercedes
  • Alegre-Sancho, Juan-José
  • Mijares, Verónica
  • Lera-Gómez, Leticia
  • Pérez-Pampin, Eva
  • González, Antonio
  • Ortega-Castro, Rafaela
  • López-Pedrera, Chary
  • García Vivar, Mari L.
  • Gómez-Arango, Catalina
  • Raya, Enrique
  • Narváez, Javier
  • Balsa, Alejandro
  • Lpez-Longo, Francisco Javier
  • Carreira, Patricia E.
  • González-Álvaro, Isidoro
  • Rodríguez-Rodríguez, Luis
  • Fernández-Gutiérrez, Benjamín
  • Ferraz-Amaro, Iván
  • Gualillo, Oreste
  • Castañeda, Santos
  • Martín, J.
  • Llorca, Javier
  • González-Gay, Miguel A.
Objective To investigate the genetic background influencing the development of cardiovascular (CV) disease in patients with rheumatoid arthritis (RA). Methods We performed a genome-wide association study (GWAS) in which, after quality control and imputation, a total of 6,308,944 polymorphisms across the whole genome were analyzed in 2,989 RA patients of European origin. Data on subclinical atherosclerosis, obtained through assessment of carotid intima-media thickness (CIMT) and presence/absence of carotid plaques by carotid ultrasonography, were available for 1,355 individuals. Results A genetic variant of the RARB gene (rs116199914) was associated with CIMT values at the genome-wide level of significance (minor allele [G] beta coefficient 0.142, P = 1.86 x 10(-8)). Interestingly, rs116199914 overlapped with regulatory elements in tissues related to CV pathophysiology and immune cells. In addition, biologic pathway enrichment and predictive protein-protein relationship analyses, including suggestive GWAS signals of potential relevance, revealed a functional enrichment of the collagen biosynthesis network related to the presence/absence of carotid plaques (Gene Ontology no. 0032964; false discovery rate-adjusted P = 4.01 x 10(-3)). Furthermore, our data suggest potential influences of the previously described candidate CV risk loci NFKB1, MSRA, and ZC3HC1 (P = 8.12 x 10(-4), P = 5.94 x 10(-4), and P = 2.46 x 10(-4), respectively). Conclusion The present findings strongly suggest that genetic variation within RARB contributes to the development of subclinical atherosclerosis in patients with RA., Supported in part by the European Union FEDER fund and the Instituto de Salud Carlos III (ISCIII) (Fondo de Investigacion Sanitaria grants PI06/0024, PS09/00748, PI12/00060, PI15/00525, and CP16/00033), the ISCIII RETICS programs (RD12/0009 and RD16/0012), the European IMI BTCure Program. Dr. Lopez-Mejias is recipient of the Miguel Servet type I Program Fellowship from the ISCIII and the European Social Fund (ESF) (grant CP16/00033). Dr. Carmona's work was supported by the Spanish Ministry of Economy and Competitiveness (Ramon y Cajal Program grant RYC-2014-16458). Dr. Genre is recipient of a Sara Borrell postdoctoral fellowship from the ISCIII and ESF (grant CD15/00095). Dr. Remuzgo-Martinez' work was supported by the ISCIII and European Regional Development Fund (ERDF) (RETICS Program RD16/0012/0009). Ms Pulito-Cueto's work was supported by a predoctoral grant from the Instituto de Investigacion Sanitaria Valdecilla (PREVAL 18/01). Ms Mijares' work was supported by the Miguel Servet type I Program from the ISCIII and ESF (grant CP16/00033). Dr. Gualillo is staff personnel of Xunta de Galicia (Servizo Galego de Saude [SERGAS]) through a research-staff stabilization contract (ISCIII/SERGAS) and his work is funded by ISCIII and FEDER (grants RD16/0012/0014 [RIER] and PI17/00409). He is beneficiary of project funds from the Research Executive Agency (REA) of the European Union in the framework of MSCA-RISE Action of the H2020 Programme, project 734899-Olive-Net., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

  • Carmona, F. David
  • Coit, Patrick
  • Saruhan-Direskeneli, Güher
  • Hernández-Rodríguez, José
  • Cid, María C.
  • Solans Laque, Roser
Estudis d'associació de genoma; Síndromes de vasculitis, Estudios de asociación de genoma; Síndromes de vasculitis, Genome-wide association studies; Vasculitis syndromes, Giant cell arteritis (GCA) and Takayasu’s arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1/HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P = 7.54E-07; ORGCA = 1.19, ORTAK = 1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (PGCA = 5.52E-04, ORGCA = 1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus., This work was supported by SAF2012–34435 from the Spanish Ministry of Economy and Competitiveness, BIO-1395 from Junta de Andalucía, and RD12/0009/0004 from the RETICS Program (RIER) of Instituto de Salud Carlos III (ISCIII). FDC was recipient of a grant from the ‘Ramón y Cajal’ programme of the Spanish Ministry of Economy and Competitiveness (RYC-2014–16458). MCC and JHR are supported by Ministerio de Economía y Competitividad (SAF 14/57708R), cofunded by “Fondo Europeo de Desarrollo Regional, Unión Europea, Una manera de hacer Europa” [Instituto de Salud Carlos III and Fondo Europeo de desarrollo regional (FEDER) (PIE 13/00033)]. The Vasculitis Clinical Research Consortium has received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319), the National Center for Research Resources (U54 RR019497), the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. The VCRC is part of the Rare Diseases Clinical Research Network (RDCRN).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

  • Carmona, F. David|||0000-0002-1427-7639
  • Coit, Patrick
  • Saruhan-Direskeneli, Güher
  • Hernández Rodríguez, José|||0000-0002-2357-2015
  • Cid, María Cinta|||0000-0002-4730-0938
  • Solans, Roser|||0000-0002-0058-1293
  • Castañeda, Santos|||0000-0002-7748-853X
  • Vaglio, Augusto
  • Direskeneli, Haner
  • Merkel, Peter A.|||0000-0001-9284-7345
  • Boiardi, Luigi
  • Salvarani, Carlo|||0000-0001-5426-5133
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Martín, Javier|||0000-0002-2202-0622
  • Sawalha, Amr H.
Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1 / HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P = 7.54E-07; OR = 1.19, OR = 1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (P = 5.52E-04, OR = 1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluation of male fertility-associated loci in a european population of patients with severe spermatogenic impairment

  • Cerván-Martín, Miriam|||0000-0001-6033-0587
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
  • Rivera-Egea, Rocío
  • Garrido, Nicolás|||0000-0001-8271-5218
  • Luján, Saturnino|||0000-0002-5005-3325
  • Romeu, Gema|||0000-0001-6365-1087
  • Santos-Ribeiro, Samuel|||0000-0003-2476-7858
  • Castilla, José Antonio|||0000-0003-2185-565X
  • Gonzálvo, María Carmen
  • Clavero, Ana
  • Vicente, F. Javier
  • Guzmán-Jiménez, Andrea|||0000-0002-2091-0568
  • Costa, Claudia|||0000-0002-7422-6139
  • Llinares-Burguet, Inés|||0000-0002-7838-0838
  • Khantham, Chiranan|||0000-0002-8385-1155
  • Burgos, Miguel|||0000-0003-4446-9313
  • Barrionuevo, Francisco J.|||0000-0003-2651-1530
  • Jiménez, Rafael|||0000-0003-4103-8219
  • Sánchez-Curbelo, Josvany|||0000-0002-6489-3309
  • López-Rodrigo, Olga|||0000-0001-9325-5835
  • Peraza, María Fernanda|||0000-0001-9924-7481
  • Pereira-Caetano, Iris
  • Marques, Patricia Isabel|||0000-0001-6050-628X
  • Carvalho, Filipa|||0000-0001-9546-4614
  • Barros, Alberto|||0000-0002-8700-3698
  • Bassas, Lluís|||0000-0002-3473-3611
  • Seixas, Susana|||0000-0002-7035-7422
  • Gonçalves, João|||0000-0001-9359-8774
  • Larriba, Sara|||0000-0003-4579-5452
  • Lopes, Alexandra M.|||0000-0003-3539-2318
  • Palomino-Morales, Rogelio J.|||0000-0003-3507-343X
  • Carmona, F. David|||0000-0002-1427-7639
Infertility is a growing concern in developed societies. Two extreme phenotypes of male infertility are non-obstructive azoospermia (NOA) and severe oligospermia (SO), which are characterized by severe spermatogenic failure (SpF). We designed a genetic association study comprising 725 Iberian infertile men as a consequence of SpF and 1058 unaffected controls to evaluate whether five single-nucleotide polymorphisms (SNPs), previously associated with reduced fertility in Hutterites, are also involved in the genetic susceptibility to idiopathic SpF and specific clinical entities. A significant difference in the allele frequencies of USP8-rs7174015 was observed under the recessive model between the NOA group and both the control group (p = 0.0226, OR = 1.33) and the SO group (p = 0.0048, OR = 1.78). Other genetic associations for EPSTI1-rs12870438 and PSAT1-rs7867029 with SO and between TUSC1-rs10966811 and testicular sperm extraction (TESE) success in the context of NOA were observed. In silico analysis of functional annotations demonstrated cis-eQTL effects of such SNPs likely due to the modification of binding motif sites for relevant transcription factors of the spermatogenic process. The findings reported here shed light on the molecular mechanisms leading to severe phenotypes of idiopathic male infertility, and may help to better understand the contribution of the common genetic variation to the development of these conditions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Immune and spermatogenesis-related loci are involved in the development of extreme patterns of male infertility

  • Cerván-Martín, Miriam|||0000-0001-6033-0587
  • Tüttelmann, Frank|||0000-0003-2745-9965
  • Lopes, Alexandra M.|||0000-0003-3539-2318
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
  • Rivera-Egea, Rocío
  • Garrido, Nicolás|||0000-0001-8271-5218
  • Luján, Saturnino|||0000-0002-5005-3325
  • Romeu, Gema|||0000-0001-6365-1087
  • Santos-Ribeiro, Samuel|||0000-0003-2476-7858
  • Castilla, José Antonio|||0000-0003-2185-565X
  • Gonzálvo, María Carmen
  • Clavero, Ana
  • Maldonado, Vicente|||0000-0003-4456-7191
  • Vicente, F.Javier
  • González-Muñoz, Sara
  • Guzmán-Jiménez, Andrea|||0000-0002-2091-0568
  • Burgos, Miguel|||0000-0003-4446-9313
  • Jiménez, Rafael|||0000-0003-4103-8219
  • Pacheco, Alberto
  • González, Cristina
  • Gómez, Susana
  • Amorós, David
  • Aguilar, Jesús
  • Quintana, Fernando|||0000-0003-4460-0270
  • Calhaz-Jorge, Carlos
  • Aguiar, Ana|||0000-0001-7841-7410
  • Nunes, Joaquim
  • Sousa, Sandra
  • Pereira, Isabel
  • Pinto, Maria Graça
  • Correia, Sónia
  • Sánchez-Curbelo, Josvany|||0000-0002-6489-3309
  • López-Rodrigo, Olga|||0000-0001-9325-5835
  • Martín, Javier|||0000-0002-2202-0622
  • Pereira-Caetano, Iris
  • Marques, Patricia I.
  • Carvalho, Filipa|||0000-0001-9546-4614
  • Barros, Alberto|||0000-0002-8700-3698
  • Gromoll, Jörg
  • Bassas, Lluís|||0000-0002-3473-3611
  • Seixas, Susana|||0000-0002-7035-7422
  • Gonçalves, João|||0000-0001-9359-8774
  • Larriba, Sara|||0000-0003-4579-5452
  • Kliesch, Sabine|||0000-0002-7561-4870
  • Palomino-Morales, Rogelio J.|||0000-0003-3507-343X
  • Carmona, F. David|||0000-0002-1427-7639
We conducted a genome-wide association study in a large population of infertile men due to unexplained spermatogenic failure (SPGF). More than seven million genetic variants were analysed in 1,274 SPGF cases and 1,951 unaffected controls from two independent European cohorts. Two genomic regions were associated with the most severe histological pattern of SPGF, defined by Sertoli cell-only (SCO) phenotype, namely the MHC class II gene HLA-DRB1 (rs1136759, P = 1.32E-08, OR = 1.80) and an upstream locus of VRK1 (rs115054029, P = 4.24E-08, OR = 3.14), which encodes a protein kinase involved in the regulation of spermatogenesis. The SCO-associated rs1136759 allele (G) determines a serine in the position 13 of the HLA-DRβ1 molecule located in the antigen-binding pocket. Overall, our data support the notion of unexplained SPGF as a complex trait influenced by common variation in the genome, with the SCO phenotype likely representing an immune-mediated condition.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Common Variation in the PIN1 Locus Increases the Genetic Risk to Suffer from Sertoli Cell-Only Syndrome

  • Cerván-Martín, Miriam|||0000-0001-6033-0587
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
  • Guzmán-Jiménez, Andrea|||0000-0002-2091-0568
  • Rivera-Egea, Rocío
  • Garrido, Nicolás|||0000-0001-8271-5218
  • Luján, Saturnino|||0000-0002-5005-3325
  • Romeu, Gema|||0000-0001-6365-1087
  • Santos-Ribeiro, Samuel|||0000-0003-2476-7858
  • Castilla, José Antonio|||0000-0003-2185-565X
  • Gonzálvo, María Carmen
  • Clavero, Ana
  • Vicente, F. Javier
  • Maldonado, Vicente|||0000-0003-4456-7191
  • González-Muñoz, Sara
  • Rodríguez-Martín, Inmaculada
  • Burgos, Miguel|||0000-0003-4446-9313
  • Jiménez, Rafael|||0000-0003-4103-8219
  • Pinto, Maria Graça
  • Pereira, Isabel
  • Nunes, Joaquim
  • Sánchez-Curbelo, Josvany|||0000-0002-6489-3309
  • López-Rodrigo, Olga|||0000-0001-9325-5835
  • Pereira-Caetano, Iris
  • Marques, Patricia Isabel|||0000-0001-6050-628X
  • Carvalho, Filipa|||0000-0001-9546-4614
  • Barros, Alberto|||0000-0002-8700-3698
  • Bassas, Lluís|||0000-0002-3473-3611
  • Seixas, Susana|||0000-0002-7035-7422
  • Gonçalves, João|||0000-0001-9359-8774
  • Larriba, Sara|||0000-0003-4579-5452
  • Lopes, AlexandraM.
  • Carmona, F. David|||0000-0002-1427-7639
  • Palomino-Morales, Rogelio J.|||0000-0003-3507-343X
We aimed to analyze the role of the common genetic variants located in the PIN1 locus, a relevant prolyl isomerase required to control the proliferation of spermatogonial stem cells and the integrity of the blood-testis barrier, in the genetic risk of developing male infertility due to a severe spermatogenic failure (SPGF). Genotyping was performed using TaqMan genotyping assays for three PIN1 taggers (rs2287839, rs2233678 and rs62105751). The study cohort included 715 males diagnosed with SPGF and classified as suffering from non-obstructive azoospermia (NOA, n = 505) or severe oligospermia (SO, n = 210), and 1058 controls from the Iberian Peninsula. The allelic frequency differences between cases and controls were analyzed by the means of logistic regression models. A subtype specific genetic association with the subset of NOA patients classified as suffering from the Sertoli cell-only (SCO) syndrome was observed with the minor alleles showing strong risk effects for this subset (ORrs2287839 = 1.85 (1.17-2.93), ORrs2233678 = 1.62 (1.11-2.36), ORrs62105751 = 1.43 (1.06-1.93)). The causal variants were predicted to affect the binding of key transcription factors and to produce an altered PIN1 gene expression and isoform balance. In conclusion, common non-coding single-nucleotide polymorphisms located in PIN1 increase the genetic risk to develop SCO.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Common genetic variation in KATNAL1 non-coding regions is involved in the susceptibility to severe phenotypes of male infertility

  • Cerván-Martín, Miriam|||0000-0001-6033-0587
  • Bossini-Castillo, Lara|||0000-0002-5471-5824
  • Guzmán-Jiménez, Andrea|||0000-0002-2091-0568
  • Rivera-Egea, Rocío
  • Garrido, Nicolás|||0000-0001-8271-5218
  • Luján, Saturnino|||0000-0002-5005-3325
  • Romeu, Gema|||0000-0001-6365-1087
  • Santos-Ribeiro, Samuel|||0000-0003-2476-7858
  • Castilla, José Antonio|||0000-0003-2185-565X
  • Gonzálvo, María Carmen
  • Clavero, Ana
  • Maldonado, Vicente|||0000-0003-4456-7191
  • Vicente, Francisco Javier
  • Burgos, Miguel|||0000-0003-4446-9313
  • Jiménez, Rafael|||0000-0003-4103-8219
  • González-Muñoz, Sara
  • Sánchez-Curbelo, Josvany|||0000-0002-6489-3309
  • López-Rodrigo, Olga|||0000-0001-9325-5835
  • Pereira-Caetano, Iris
  • Marques, Patricia Isabel|||0000-0001-6050-628X
  • Carvalho, Filipa|||0000-0001-9546-4614
  • Barros, Alberto|||0000-0002-8700-3698
  • Bassas, Lluís|||0000-0002-3473-3611
  • Seixas, Susana|||0000-0002-7035-7422
  • Gonçalves, João|||0000-0001-9359-8774
  • Larriba, Sara|||0000-0003-4579-5452
  • Lopes, Alexandra M.|||0000-0003-3539-2318
  • Palomino-Morales, Rogelio Jesús
  • Carmona, F. David|||0000-0002-1427-7639
Background: Previous studies in animal models evidenced that genetic mutations of KATNAL1, resulting in dysfunction of its encoded protein, lead to male infertility through disruption of microtubule remodelling and premature germ cell exfoliation. Subsequent studies in humans also suggested a possible role of KATNAL1 single-nucleotide polymorphisms in the development of male infertility as a consequence of severe spermatogenic failure. Objectives: The main objective of the present study is to evaluate the effect of the common genetic variation of KATNAL1 in a large and phenotypically well-characterised cohort of infertile men because of severe spermatogenic failure. Materials and methods: A total of 715 infertile men because of severe spermatogenic failure, including 210 severe oligospermia and 505 non-obstructive azoospermia patients, as well as 1058 unaffected controls were genotyped for three KATNAL1 single-nucleotide polymorphism taggers (rs2077011, rs7338931 and rs2149971). Case-control association analyses by logistic regression assuming different models and in silico functional characterisation of risk variants were conducted. Results: Genetic associations were observed between the three analysed taggers and different severe spermatogenic failure groups. However, in all cases, the haplotype model (rs2077011*C | rs7338931*T | rs2149971*A) better explained the observed associations than the three risk alleles independently. This haplotype was associated with non-obstructive azoospermia (adjusted p = 4.96E-02, odds ratio = 2.97), Sertoli-cell only syndrome (adjusted p = 2.83E-02, odds ratio = 5.16) and testicular sperm extraction unsuccessful outcomes (adjusted p = 8.99E-04, odds ratio = 6.13). The in silico analyses indicated that the effect on severe spermatogenic failure predisposition could be because of an alteration of the KATNAL1 splicing pattern. Conclusions: Specific allelic combinations of KATNAL1 genetic polymorphisms may confer a risk of developing severe male infertility phenotypes by favouring the overrepresentation of a short non-functional transcript isoform in the testis.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy

  • Carmona, F. David
  • Coit, Patrick
  • Saruhan-Direskeneli, Güher
  • Hernández-Rodríguez, José
  • Cid, María C.
  • Solans Laque, Roser
Estudis d'associació de genoma; Síndromes de vasculitis, Estudios de asociación de genoma; Síndromes de vasculitis, Genome-wide association studies; Vasculitis syndromes, Giant cell arteritis (GCA) and Takayasu’s arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1/HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P = 7.54E-07; ORGCA = 1.19, ORTAK = 1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (PGCA = 5.52E-04, ORGCA = 1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus., This work was supported by SAF2012–34435 from the Spanish Ministry of Economy and Competitiveness, BIO-1395 from Junta de Andalucía, and RD12/0009/0004 from the RETICS Program (RIER) of Instituto de Salud Carlos III (ISCIII). FDC was recipient of a grant from the ‘Ramón y Cajal’ programme of the Spanish Ministry of Economy and Competitiveness (RYC-2014–16458). MCC and JHR are supported by Ministerio de Economía y Competitividad (SAF 14/57708R), cofunded by “Fondo Europeo de Desarrollo Regional, Unión Europea, Una manera de hacer Europa” [Instituto de Salud Carlos III and Fondo Europeo de desarrollo regional (FEDER) (PIE 13/00033)]. The Vasculitis Clinical Research Consortium has received support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319), the National Center for Research Resources (U54 RR019497), the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. The VCRC is part of the Rare Diseases Clinical Research Network (RDCRN).